Dry eye disease is a condition that afflicts millions of people worldwide, causing constant discomfort and affecting their quality of life. One of the key culprits behind this condition is meibomian ...

Dry eye disease (DED) is a common source of eye pain, grittiness, tearing, and discomfort. It affects at least 17 million people in the United States and as many as 60 million people worldwide. As the ...

The average American spends nearly seven hours a day looking at screens, reports have shown — and all of that phone, tablet and computer gazing can take a toll on the eyes. One of the effects of ...

You’ve probably never heard of Meibomian Gland Dysfunction. But chances are, you may experience it at some point in your life. It’s something 69 News reporter Jaccii Farris knows firsthand. Over the ...

TEL AVIV, Israel--(BUSINESS WIRE)--Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a new therapeutic class of Ophthalmic Keratolytics for ocular surface diseases, today ...

AZR-MD-001 0.5% meets co-primary efficacy endpoints, making it the first investigational drug to show significant improvements in both signs and symptoms of Meibomian Gland Dysfunction Restoration of ...

Ocular surface disease (OSD) develops from a combination of adverse conditions that ultimately damage the surface layers of the eye. While the early symptoms of ocular surface disease might amount to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Tarsus presented data showing Xdemvy improved gland ...

Dry eye syndrome affects millions of Americans, significantly impacting quality of life and vision, yet often remains undertreated. The Envision by InMode system represents a paradigm shift in dry eye ...

Please provide your email address to receive an email when new articles are posted on . Subjective grading was significantly different between Visante OCT and Keratograph 5M for the lower eyelid but ...